In fact, whether C3a is pro-inflammatory or anti-inflammatory is not mutually exclusive in the pathogenesis of NAFLD, but depends on the balance between pro-inflammatory and anti-inflammatory effects of C3a, which determines the final outcome of the disease (Figure 3). The gene discussed is C3; the disease is metabolic dysfunction-associated steatotic liver disease.